Michal Laufer‐Perl

Also affiliated with Tel Aviv Sourasky Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Immune checkpoint inhibitor-associated myocarditis: a novel risk score”.

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

European Heart Journal(2025)10.1093/eurheartj/ehaf315

N/A

1.1DataRank · unranked

47 citations

Charles Dolladille, Benay Ozbay, Adrien Procureur, Stéphane Éderhy, Nicolas L. Palaskas +92 more

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity

medRxiv(2024)10.1101/2024.06.02.24308336

N/A

0.383DataRank · unranked

6 citations

Charles Dolladille, Adriel Procureur, Stéphane Éderhy, Nicolas L. Palaskas, Lorenz Lehmann +47 more

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Archives of cardiovascular diseases(2022)10.1016/j.acvd.2022.03.003

N/A

0DataRank · unranked

40 citations

Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani +61 more

Atrial Mechanics, Atrial Cardiomyopathy and Impact of Atrial Interventions

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2024.06.017

N/A

0DataRank · unranked

11 citations

Michal Laufer‐Perl, K. Balakumaran, Maria Rosa Costanzo, Thomas H. Marwick, Fawaz Alenezi +14 more

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction

JACC CardioOncology(2025)10.1016/j.jaccao.2025.01.020

N/A

0DataRank · unranked

21 citations

Charles Dolladille, Anjali Rao, Nicolas L. Palaskas, Anita Deswal, Lorenz Lehmann +51 more